Free Trial

Accolade (ACCD) Stock Forecast & Price Target

Accolade logo
$3.42 -0.03 (-0.87%)
(As of 11:32 AM ET)

Accolade - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
3
Buy
11

Based on 14 Wall Street analysts who have issued ratings for Accolade in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 14 analysts, 3 have given a hold rating, and 11 have given a buy rating for ACCD.

Consensus Price Target

$8.96
161.94% Upside
According to the 14 analysts' twelve-month price targets for Accolade, the average price target is $8.96. The highest price target for ACCD is $16.00, while the lowest price target for ACCD is $5.00. The average price target represents a forecasted upside of 161.94% from the current price of $3.42.
Get the Latest News and Ratings for ACCD and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Accolade and its competitors.

Sign Up

ACCD Analyst Ratings Over Time

TypeCurrent Forecast
12/25/23 to 12/24/24
1 Month Ago
11/25/23 to 11/24/24
3 Months Ago
9/26/23 to 9/25/24
1 Year Ago
12/25/22 to 12/25/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
11 Buy rating(s)
12 Buy rating(s)
12 Buy rating(s)
10 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$8.96$9.04$11.65$15.14
Forecasted Upside161.94% Upside144.37% Upside207.49% Upside29.54% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

ACCD Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ACCD Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Accolade Stock vs. The Competition

TypeAccoladeBusiness Services CompaniesS&P 500
Consensus Rating Score
2.79
2.69
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside159.66% Upside154.62% Upside14.28% Upside
News Sentiment Rating
Neutral News

See Recent ACCD News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/17/2024Morgan Stanley
3 of 5 stars
 Lower TargetEqual Weight ➝ Equal Weight$6.00 ➝ $5.00+44.51%
10/11/2024Wells Fargo & Company
3 of 5 stars
 Lower TargetEqual Weight ➝ Equal Weight$7.00 ➝ $6.00+59.57%
10/9/2024Canaccord Genuity Group
1 of 5 stars
 Lower TargetBuy ➝ Buy$13.00 ➝ $7.00+75.88%
10/9/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$9.00 ➝ $7.50+88.44%
10/9/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$10.00 ➝ $8.00+95.60%
10/9/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight$5.50 ➝ $5.00+22.25%
10/7/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$8.00 ➝ $8.00+113.33%
6/28/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$13.00 ➝ $8.00+117.98%
6/28/2024Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$13.00 ➝ $6.00+63.49%
2/26/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Cherny
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
2/26/2024Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$16.00+56.56%
1/9/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform
1/9/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$12.00 ➝ $15.00+29.09%
1/9/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$12.00 ➝ $16.00+37.69%
12/6/2023DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
G. Luria
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
10/5/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$19.00 ➝ $16.00+64.10%
6/30/2023VNET Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingReiterates
6/30/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$13.00 ➝ $15.00+18.67%
2/9/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$14.00+11.29%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 11:53 AM ET.


ACCD Forecast - Frequently Asked Questions

According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Accolade is $8.96, with a high forecast of $16.00 and a low forecast of $5.00.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Accolade in the last twelve months. There are currently 3 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ACCD shares.

According to analysts, Accolade's stock has a predicted upside of 161.94% based on their 12-month stock forecasts.

Accolade has been rated by research analysts at Barclays, Canaccord Genuity Group, Morgan Stanley, Needham & Company LLC, Stephens, Truist Financial, and Wells Fargo & Company in the past 90 days.

Analysts like Accolade more than other "business services" companies. The consensus rating score for Accolade is 2.79 while the average consensus rating score for "business services" companies is 2.69. Learn more on how ACCD compares to other companies.


This page (NASDAQ:ACCD) was last updated on 12/24/2024 by MarketBeat.com Staff
From Our Partners